Dr. Suchi Acharya, Founder and CEO, brings over 20 years of experience in pharmaceutical drug discovery, development, clinical trials, and project management. Prior to AyuVis, she spent 12 years in leadership roles with Alcon Labs/Novartis and led R&D projects in ophthalmology. She is an innovative scientist, inventor of patents, and managed small molecule drug discovery projects from hit to lead, lead optimization, Phase 1-3 clinical trials, and commercialization. She is a trained regulatory professional with experience in interacting with the FDA. Dr. Acharya founded AyuVis in 2014 and designed and developed novel, small molecule immunotherapies that fight inflammation and infection with a unique mode of action. As the CEO of AyuVis, she has extensive experience in starting a private company, fundraising, writing and receiving government (NIH) grants, publishing in scientific journals, international business and tax benefit opportunities, and strategic planning in all areas.